SCIATICA FORMULA (caffeine (coffeinum) 6x, hemp extract- cannabis sativa 2x spray Stati Uniti - inglese - NLM (National Library of Medicine)

sciatica formula (caffeine (coffeinum) 6x, hemp extract- cannabis sativa 2x spray

protege' media llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e), cannabis sativa subsp. sativa flowering top (unii: 8x454sz22d) (cannabis sativa subsp. sativa flowering top - unii:8x454sz22d) - caffeine (coffeinum) 6x (0.0018mg) hpus                                                 analgesic hemp extract (cannabis sativa) 2x (11.3 mg) hpus                                    anti-inflammatory approximately 158 sprays per container reference: the homeopathic pharmacopoeia of the united states (hpus)

Caffeine Gummies Australia - inglese - Department of Health (Therapeutic Goods Administration)

caffeine gummies

bsps aust pty ltd - pyridoxine hydrochloride, quantity: 632 microgram (equivalent: pyridoxine, qty 400 microgram); ascorbic acid, quantity: 12 mg; nicotinamide, quantity: 3.6 mg; paullinia cupana, quantity: 82.5 mg (equivalent: paullinia cupana, qty 247.5 mg; equivalent: caffeine, qty 7.5 mg); cyanocobalamin, quantity: 0.2 microgram; caffeine, quantity: 7.5 mg - pastille - excipient ingredients: gelatin; sucrose; maltodextrin; caramel; liquid glucose; purified water; citric acid; colour; flavour - enhance/promote energy levels ; decrease/reduce mental/cognitive fatigue ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase mental endurance/stamina ; enhance/improve/promote/increase mental alertness/wakefulness

Caffeine Gummies Australia - inglese - Department of Health (Therapeutic Goods Administration)

caffeine gummies

bsps aust pty ltd - pyridoxine hydrochloride, quantity: 632 microgram (equivalent: pyridoxine, qty 400 microgram); ascorbic acid, quantity: 12 mg; nicotinamide, quantity: 3.6 mg; paullinia cupana, quantity: 82.5 mg (equivalent: paullinia cupana, qty 247.5 mg; equivalent: caffeine, qty 7.5 mg); cyanocobalamin, quantity: 0.2 microgram; caffeine, quantity: 7.5 mg - pastille - excipient ingredients: gelatin; sucrose; maltodextrin; caramel; liquid glucose; purified water; citric acid; colour; flavour - enhance/promote energy levels ; decrease/reduce mental/cognitive fatigue ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase mental endurance/stamina ; enhance/improve/promote/increase mental alertness/wakefulness

Caffeine Energy + Multivitamin Australia - inglese - Department of Health (Therapeutic Goods Administration)

caffeine energy + multivitamin

bsps aust pty ltd - caffeine, quantity: 40 mg; thiamine hydrochloride, quantity: 2.21 mg (equivalent: thiamine, qty 1.5 mg); paullinia cupana, quantity: 273 mg (equivalent: paullinia cupana, qty 956 mg; equivalent: caffeine, qty 60 mg); calcium carbonate, quantity: 253.17 mg (equivalent: calcium, qty 100 mg); zinc gluconate, quantity: 82.99 mg (equivalent: zinc, qty 10 mg); ascorbic acid, quantity: 60 mg; calcium pantothenate, quantity: 7.43 mg (equivalent: pantothenic acid, qty 6 mg); cyanocobalamin, quantity: 2.5 microgram; pyridoxine hydrochloride, quantity: 2.72 mg (equivalent: pyridoxine, qty 2 mg); riboflavin sodium phosphate, quantity: 2.49 mg (equivalent: riboflavin, qty 1.6 mg); folic acid, quantity: 200 microgram; biotin, quantity: 150 microgram; magnesium carbonate hydrate, quantity: 400 mg (equivalent: magnesium, qty 100 mg); nicotinamide, quantity: 18 mg - tablet, effervescent - excipient ingredients: citric acid; glucose; sodium bicarbonate; sucralose; macrogol 4000; maltodextrin; beetroot; flavour - antioxidant/reduce free radicals formed in the body ; enhance/promote energy levels ; maintain/support energy production ; maintain/support general health and wellbeing ; decrease/reduce mental/cognitive fatigue ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase mental endurance/stamina ; enhance/improve/promote/increase mental alertness/wakefulness

Lemsip Cough and Cold Capsules with CaffeineParacetamol 500mgGuaifenesin 100mgCaffeine 25mg Irlanda - inglese - HPRA (Health Products Regulatory Authority)

lemsip cough and cold capsules with caffeineparacetamol 500mgguaifenesin 100mgcaffeine 25mg

reckitt benckiser ireland ltd - paracetamol; guaifenesin; caffeine anhydrous - capsule, hard - 500 mg/100 mg/25 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Lemsip Cold & Flu Capsules with CaffeineParacetamol 500mg Caffeine 65mg Irlanda - inglese - HPRA (Health Products Regulatory Authority)

lemsip cold & flu capsules with caffeineparacetamol 500mg caffeine 65mg

reckitt benckiser ireland ltd - paracetamol; caffeine - capsule, hard - 500mg/65 milligram(s) - anilides; paracetamol

Lemsip Decongestant & Flu Capsules with CaffeineParacetamol 500mgPhenylephine Hydrochloride 6.1mgCaffeine 25mg Irlanda - inglese - HPRA (Health Products Regulatory Authority)

lemsip decongestant & flu capsules with caffeineparacetamol 500mgphenylephine hydrochloride 6.1mgcaffeine 25mg

reckitt benckiser ireland ltd - paracetamol; phenylephrine hydrochloride; caffeine anhydrous - capsule, hard - 500 mg/6.1 mg/25 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Panadol with Caffeine 500mg/ 65mg Film Coated Tablets Irlanda - inglese - HPRA (Health Products Regulatory Authority)

panadol with caffeine 500mg/ 65mg film coated tablets

haleon ireland limited - paracetamol; caffeine - film-coated tablet - 500 mg/65 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN AND CAFFEINE tablet Stati Uniti - inglese - NLM (National Library of Medicine)

dihydrocodeine bitartrate, acetaminophen and caffeine tablet

physicians total care, inc. - dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - dihydrocodeine bitartrate 32 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the relief of moderate to moderately severe pain. this combination product is contraindicated in persons with hypersensitivity to dihydrocodeine, codeine, acetaminophen, caffeine, or any of the inactive components listed above, or any situation where opioids are contraindicated including significant respiratory depression (in unmonitored settings or in the absence of resuscitative equipment), acute or severe bronchial asthma or hypercapnia, and paralytic ileus. this combination product is subject to the provisions of the controlled substance act, and has been placed in schedule iii. dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. like other opioid analgesics, dihydrocodeine may produce subjective effects other than analgesia (e.g., euphoria, relaxation), which may contribute to abuse by some patients. psychological dependence, physical dependence, and tolerance may d